<DOC>
	<DOCNO>NCT02982798</DOCNO>
	<brief_summary>A randomized , open-label , single dose , crossover study compare pharmacokinetic characteristic co-administration metformin SR rosuvastatin JLP-1310 healthy male volunteer</brief_summary>
	<brief_title>The PK Characteristics Co-administration Metformin SR Rosuvastatin JLP-1310 Healthy Male Volunteers</brief_title>
	<detailed_description>A randomized , open-label , single dose , crossover clinical trial</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy male volunteer , age 19 year Body weight 55kg , The result Body Mass Index ( BMI ) less 17.5 kg/m2 , 30.5 kg/m2 Subject ability comprehend study objective , content property study drug participate trial Subject ability willingness participate whole period trial Presence medical history concurrent disease may interfere treatment safety assessment completion clinical study , include clinically significant disorder kidney , liver , cardiovascular system , respiratory system , endocrine system , neuropsychiatric system . Subjects allergic investigational drug . Subjects medical history affect clinical trial . Systolic BP &gt; 140mmHG Diastolic BP &gt; 90mmHg ) AST ALT &gt; X 2 UNL History drug abuse positive drug screening . Participation drug study within 3 month prior drug administration . Whole blood donation within 60 day , blood component donation within 30 day get transfusion within 30days .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>